PANews reported on December 20th that cryptocurrency exchange Gemini announced on its X platform that it has signed a joint letter with over 125 companies and organizationsPANews reported on December 20th that cryptocurrency exchange Gemini announced on its X platform that it has signed a joint letter with over 125 companies and organizations

Gemini signed a joint letter defending the original intent of the Genius Act: trading intermediary platforms should be allowed to continue offering stablecoin rewards.

2025/12/20 17:01

PANews reported on December 20th that cryptocurrency exchange Gemini announced on its X platform that it has signed a joint letter with over 125 companies and organizations, urging the U.S. Congress to uphold the original text of the Genius Act and not amend it. It is understood that legitimate stablecoin rewards benefit consumers and competition and are legally permitted under the Genius Act; revising the act would undermine certainty and innovation. Gemini co-founder Tyler Winklevoss further explained that while the current Genius Act prohibits stablecoin issuers from offering stablecoin rewards, trading platforms like Gemini, Coinbase, and Kraken can, and this is already included in the existing legislation. If traditional bankers amend the act to prohibit such behavior, it will stifle stablecoin innovation.

Market Opportunity
The AI Prophecy Logo
The AI Prophecy Price(ACT)
$0,03963
$0,03963$0,03963
+21,52%
USD
The AI Prophecy (ACT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.